KORU Medical Systems, Inc. KRMD

Full chart Compare
Set alert

Price alert · KRMD

All alert types
3.09 USD +0.04 (+1.31%)

Nov 3, 2026, 3:18 PM EST

2.99 Day range 3.13
2.86 52-week range 6.61
YTD
-46.82%
1 year
-19.53%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 4.90 +58.6% upside
Target (low)
3.50
Target (mean)
4.90
Target (high)
7.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

KRMD analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.0325-0.04 – -0.02-0.02-62.5%8.13M+13.1%4
Next quarter-0.0275-0.04 – -0.02-0.02-37.5%8.78M+7.1%4
Current year-0.105-0.14 – -0.07-0.13+19.2%32.93M+15.5%4
Next year-0.0775-0.10 – -0.05-0.105+26.2%38.11M+15.7%4

Upgrades and downgrades

The latest rating changes

KRMD analyst upgrades and downgrades
DateFirmActionFromTo
Nov 14, 2024Craig-HallumMaintainedBuyBuy
Nov 14, 2024Canaccord GenuityMaintainedBuyBuy
Nov 14, 2024Piper SandlerMaintainedOverweightOverweight
Aug 8, 2024Piper SandlerMaintainedOverweightOverweight
Mar 14, 2024B. Riley SecuritiesReiteratedBuyBuy
Dec 7, 2023Canaccord GenuityReiteratedBuyBuy
Sep 7, 2023Lake StreetInitiated—Buy
Sep 7, 2023B. Riley SecuritiesInitiated—Buy
Aug 3, 2023Piper SandlerMaintainedOverweightOverweight
Jan 6, 2023Piper SandlerMaintained—Overweight
Nov 10, 2022Canaccord GenuityUpgradeHoldBuy
Nov 10, 2022Piper SandlerUpgradeNeutralOverweight
Jan 26, 2021Canaccord GenuityDowngradeBuyHold
Jan 26, 2021Piper SandlerDowngradeOverweightNeutral
Nov 5, 2020Canaccord GenuityMaintained—Buy
Jul 16, 2020Canaccord GenuityInitiated—Buy
Jun 24, 2020Piper SandlerInitiated—Overweight